Davide Sciuscio

Suggest Changes
Learn More
The methylation status of the O6-methylguanine-DNA methyltransferase (MGMT) gene is an important predictive biomarker for benefit from alkylating agent therapy in glioblastoma. Recent studies in(More)
In this work, a first attempt to set-up a new in vitro experimental protocol with culture in liquid medium and flow cytometry analysis of bone marrow progenitors is described. This protocol is(More)
One of the methylation probe names in the abstract was misspelled and should read cg12434587 (not cg1243587). The authors wish to add the following statement that was missing in the Acknowledgments:(More)